Form 4: AngioDynamics Executive Disposes Shares for Tax Obligations
Insider Transaction Report
AngioDynamics SVP/GM Chad Thomas Campbell reported the disposition of 1,779 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- Chad Thomas Campbell, SVP/GM, Vascular Access at AngioDynamics Inc. (ANGO), reported three separate dispositions of common stock.
- On July 19, 2025, 1,025 shares were disposed of at a price of $8.69 per share to satisfy tax withholding obligations from restricted stock units granted on July 19, 2023.
- On July 20, 2025, 359 shares were disposed of at a price of $8.69 per share for tax withholding related to restricted stock units granted on July 20, 2022.
- On July 21, 2025, 395 shares were disposed of at a price of $8.99 per share for tax withholding related to restricted stock units granted on July 21, 2021.
- Following these transactions, Mr. Campbell beneficially owns 92,297 shares of AngioDynamics common stock.
- The total number of shares disposed across the three transactions is 1,779.
Sentiment
Score: 5
Explanation: The filing reports routine tax-related dispositions of shares by an executive upon RSU vesting. This is a common and expected event in executive compensation and does not indicate a discretionary sale or change in the executive's confidence in the company. Therefore, the sentiment is neutral.
Positives
- The transactions represent the vesting of restricted stock units, indicating the executive's continued equity compensation and retention by the company.
- The executive retains a significant beneficial ownership of 92,297 shares, demonstrating continued alignment with shareholder interests.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future performance.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction and does not provide broader insights into industry trends or competitive dynamics within the medical device or vascular access sectors.
Stakeholder Impact
- Shareholders: Minimal direct impact as these are routine tax-related dispositions and not discretionary sales. The executive retains significant ownership.
- Employees: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 07/21/2021 | Grant date of restricted stock units, for which 395 shares were disposed on July 21, 2025, to satisfy tax withholding. |
| 07/20/2022 | Grant date of restricted stock units, for which 359 shares were disposed on July 20, 2025, to satisfy tax withholding. |
| 07/19/2023 | Grant date of restricted stock units, for which 1,025 shares were disposed on July 19, 2025, to satisfy tax withholding. |
| 07/19/2025 | Transaction date for the disposition of 1,025 shares of common stock. |
| 07/20/2025 | Transaction date for the disposition of 359 shares of common stock. |
| 07/21/2025 | Transaction date for the disposition of 395 shares of common stock. |
| 07/22/2025 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 reports routine tax-related dispositions of shares by an executive upon RSU vesting, which is a common and expected event in executive compensation. It does not indicate a discretionary sale or change in the executive's confidence in the company, nor does it provide new financial or operational insights that would warrant a change in investment recommendation. The executive retains a substantial beneficial ownership, suggesting continued alignment with company performance. Therefore, a 'hold' recommendation is appropriate as this filing does not present new information to alter an existing investment thesis.
Keywords
AngioDynamics, ANGO, Form 4, Insider Transaction, Stock Disposition, Restricted Stock Units, RSU, Tax Withholding, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.